Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UI111 and UIC202006 in Healthy Adult Volunteers Under Fed State Conditions
NCT07691268Phase 1Completed
- Sponsor
- Korea United Pharm Inc.
- Start
- Feb 2025
- Primary completion
- Mar 2025
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in dyslipidemia (2 arms), sponsored by Korea United Pharm Inc. Primary endpoints: Area Under the Concentration-Time Curve From Time Zero to the Last Quantifiable Concentration at 72 hours and Maximum Observed Plasma Concentration at 72 hours. Started Feb 2025; status: completed.
02
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT07691268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07691268.